Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Case series of successful treatment with fecal microbiota transplant (FMT) oral capsules mixed from multiple donors even in patients previously treated with FMT enemas for recurrent Clostridium difficile infection

Research output: Contribution to journalJournal articleResearchpeer-review

  1. A national center for persistent severe pain after groin hernia repair: Five-year prospective data

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Classification of death causes after transplantation (CLASS): Evaluation of methodology and initial results

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cerebrospinal fluid pleocytosis in infectious and noninfectious central nervous system disease: A retrospective cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Global longitudinal strain predicts incident atrial fibrillation and stroke occurrence after acute myocardial infarction

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Increased abundance of proteobacteria in aggressive Crohn's disease seven years after diagnosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prevalence of Infective Endocarditis in Enterococcus faecalis Bacteremia

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

RATIONALE: Studies have shown that fecal microbiota transplantation (FMT) is a safe and highly efficient treatment for recurrent Clostridium difficile infection (rCDI). However, it is still unknown if one versus multiple donors or enemas versus capsule FMT are most efficient.

PATIENT CONCERNS: 10 patients with at least 3 previous episodes of CDI were offered treatment with FMT capsules. 9 patients decided to participate.

DIAGNOSES: In this study, we treated 9 patients (25-86 years) with rCDI.

INTERVENTIONS: From October to November 2016, a total of 9 patients with recurrent CDI were treated with oral fecal microbiota capsules, with mixed donor feces from 4 donors with high microbiota diversity. All patients received treatment with vancomycin prior to the capsule regime.

OUTCOME: Patients had previous recurrences ranging from 2 to 10 recurrences. All 9 patients were successfully treated without recurrence after 180 days follow-up, even 2 patients previously treated with FMT enemas.

LESSONS: FMT capsules based on multiple donors are highly efficient in patients with rCDI.

Original languageEnglish
JournalMedicine (United States)
Volume97
Issue number31
ISSN0025-7974
DOIs
Publication statusPublished - 1 Aug 2018

ID: 54904605